TITLE

Efficacy and Safety of NNC0109-0012 (anti-IL-20 mAb) in Patients with RA: Results from a Phase 2a Trial

AUTHOR(S)
Vinall, Maria
PUB. DATE
August 2012
SOURCE
MD Conference Express;Aug2012, p9
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses a study which investigates the safety and efficacy of NNC0109-0012, an anti-interleukin-20 (anti-IL-20) agent, in patients with rheumatoid arthritis (RA). The study examined a total of 67 patients with active RA and used a randomized multicenter, double-blind, multiple-dose, placebo-controlled Phase 2a trial to evaluate the disease activity. Results show that 75.5% of the patients experienced good or moderate response.
ACCESSION #
80132327

 

Related Articles

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics